Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).

@article{Marin2007PreventionOV,
  title={Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).},
  author={Mona Marin and Dalya G{\"u}riş and Sandra Dos Santos Chaves and Scott D Schmid and Jane F. Seward},
  journal={MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports},
  year={2007},
  volume={56 RR-4},
  pages={1-40}
}
Two live, attenuated varicella zoster virus-containing vaccines are available in the United States for prevention of varicella: 1) a single-antigen varicella vaccine (VARIVAX, Merck & Co., Inc., Whitehouse Station, New Jersey), which was licensed in the United States in 1995 for use among healthy children aged > or = 12 months, adolescents, and adults; and 2) a combination measles, mumps, rubella, and varicella vaccine (ProQuad, Merck & Co., Inc., Whitehouse Station, New Jersey), which was… CONTINUE READING
Highly Influential
This paper has highly influenced 23 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 310 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 198 references

ProQuad (measles, mumps, rubella, and varicella [Oka/Merck] virus vaccine live)[Package insert

  • Merck, Co, Inc
  • Whitehouse Station, NJ: Merck & Co.,
  • 2005
Highly Influential
4 Excerpts

VARIVAX [Package insert

  • Merck, Co, Inc
  • Whitehouse Station, NJ: Merck & Co.,
  • 1995
Highly Influential
9 Excerpts

Primary immune failure after one dose of varicella vaccine are likely a cause of breakthrough infections in healthy vaccinated children

  • DE Michalik, PS LaRussa, SP Steinberg, P Wright, K Edwards, AA. Gershon
  • Infectious Disease Society of America Annual…
  • 2006
Highly Influential
3 Excerpts

Similar Papers

Loading similar papers…